The title compound, C 16 H 26 NO 2 + ÁC 7 H 5 O 2 À , is a benzoate salt of the painkiller Tramadol. The six-membered cyclohexane ring of the cation adopts a slightly distorted chair conformation and carries OH and 3-methoxyphenyl substituents at the 2-position and a protonated methylazaniumylmethyl group at the 3-position. In addition, a weak intramolecular C-HÁ Á ÁO hydrogen bond is observed in the cation. In the crystal, weak O-HÁ Á ÁO, N-HÁ Á ÁO and C-HÁ Á ÁO hydrogen bonds link the components into chains along [010]. A C-HÁ Á Á contact is also observed. 
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Cg1 is the centroid of the C1-C6 benzene ring. Symmetry codes: (i) x þ 1; y; z; (ii) x þ 1; y À 1; z; (iii) x; y þ 1; z.
Data collection: CrystalClear SM Expert (Rigaku, 2011) ; cell refinement: CrystalClear SM Expert; data reduction: CrystalClear SM Expert; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ); program(s) used to refine structure: SHELXL2014 (Sheldrick, 2015) ; molecular graphics: OLEX2 (Dolomanov et al., 2009) and Mercury (Macrae et al., 2008) ; software used to prepare material for publication: OLEX2.
S1. Comment
2-((dimethylamino)methyl)-1-(3-methoxyphenyl)cyclohexanol hydrochloride (Tramadol) is used in the treatment of disorders of the central nervous system and in treating extreme pain. This molecule is analogous to the phenanthrene alkaloid codeine and is used in the control of pre-operative pain (Scott & Perry, 2000) .
There are number of crystal structures reported available related to this salt. These include Venlafaxine (Arman et al., 2010) , 2,3-diaminopyridinium benzoate benzoic acid solvate (Hemamalini & Fun, 2010) , Tramadol hydrochloride-benzoic acid (1/1) (Siddaraju et al., 2011) , 4-(cyclo-propane-carboxamido) benzoic acid (Sun et al., 2012) , 3,5-bis[(pyridin-4-yl)meth-oxy]benzoic acid (Lin & Zhang, 2013) . The hydrogen-bonded two-and three-dimensional polymeric structures of the ammonium salts of 3,5-dinitro-benzoic acid, 4-nitro-benzoic acid and 2,4-di-chloro-benzoic acid (Smith, 2014) and 4-[1-(2-hydroxypropyl)-4,5-diphenyl-1H-imidazol-2-yl]benzoic acid (Jasinski et al., 2015) have also been reported. In the view of the importance of Tramadol, we report herein the crystal structure of the title compound 2-hydroxy-2-(3-methoxy-phenyl)-cyclohexylmethyl-dimethyl-ammonium benzoate.
In the title molecule ( Fig. 1) , the six membered cyclohexane ring (C9/C11-C15) adopts a slightly distorted chair conformation with ring puckering parameters Q, θ and φ of 0.5605 (16) 
S2. Experimental
Tramadol (3 g, 0.01 mol) and benzoic acid (1 g, 0.01 mol) were each dissolved in 10 ml of ethanol. The solutions were mixed and stirred in a beaker at 333 K for 30 minutes. The mixture was kept aside for three days at room temperature.
Colourless X-ray quality crystals were formed and one was used for the data collection
S3. Refinement
Crystal data, data collection and structure refinement details are summarized in Table 1 A view of the title molecule, with atom labelling. Displacement ellipsoids are drawn at the 50% probability level and an intramolecular hydrogen bond is drawn as a dashed line.
Figure 2
A viewed along the a axis of the crystal packing of the title compound. Hydrogen bonds are drawn as a dashed lines.
{[2-Hydroxy-2-(3-methoxyphenyl)cyclohexyl]methyl}dimethylammonium benzoate
Crystal data Hydrogen-bond geometry (Å, º) Cg1 is the centroid of the C1-C6 benzene ring. 
